https://www.selleckchem.com/pr....oducts/SB-525334.htm
On the other hand, an AAF should be considered for infants with persistent symptoms; the AAF should be continued if the symptoms resolve within 2-4weeks, with particular attention to the growth and nutritional status. In cases with no symptomatic improvements after the introduction of an AAF, other measures should be followed. The panel developed a management algorithm, which achieved an agreement level of 90.9%. This consensus document combined the best available evidence and clinical experience to optimize the management of CMPA in